Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: A 9-year longitudinal study of the D.E.S.I.R. cohort

International Journal of Epidemiology

Volumn 44, Issue 6, 2015, Pages 1927-1940

  Da Silva, Marine Azevedo ^a,b   Dugravot, Aline ^a,b   Balkau, Beverley ^a,b   Roussel, Ronan ^c,d,e   Fumeron, Frédéric ^d,e   Elbaz, Alexis ^a,b   Canonico, Marianne ^a,b   Singh Manoux, Archana ^a,b,f   Nabi, Hermann ^a,b   Balkau, B ^a   Ducimetiere P ^a   Eschwege E ^a   Alhenc Gelas, F ^g   Gallois, Y ^h   Girault, A ^h   Fumeron, F ⁱ   Marre, M ⁱ   Roussel, R ⁱ   Bonnet, F ^j   Cauchi, S ^k   Froguel, P ^k   Alencon ^l   Angers, ^l   Blois, ^l   Caen, ^l   Chateauroux, ^l   Chartres, ^l   Cholet, ^l   Mans, Le ^l   Orleans ^l   Tours, ^l   Cogneau, J ^m   Born, C ⁿ   Caces, E ⁿ   Cailleau, M ⁿ   Lantieri, O ⁿ   Moreau, J G ⁿ   Rakotozafy, F ⁿ   Tichet, J ⁿ   Vol, S ⁿ   more..

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g INSERM   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ BICHAT HOSPITAL   (France)

^j RENNES UNIVERSITY HOSPITAL   (France)

^k Institut Pasteur de Lille   (France)

^l Institut inter Régional pour la Santé   (France)

^m Institute de Recherche Médecine Générale   (France)

ⁿ General practitioners of the region Institute inter Regional pour la Santé   (France)

more..

Author keywords

Antidepressant; Cohort study; Fasting plasma glucose; Glucose dysregulation; HbA1c; HOMA2 B; HOMA2 S; Prospective study

Indexed keywords

AMINEPTINE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CARPIPRAMINE; CHLORIDE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; HEMOGLOBIN A1C; IMIPRAMINE; INSULIN; IPRONIAZID; MACLOBEMIDE; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; NIALAMIDE; PAROXETINE; PROPIZEPINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOLAXATONE; TRIMIPRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VILOXAZINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

CELLS AND CELL COMPONENTS; COHORT ANALYSIS; DIABETES; DRUG; GLUCOSE; METABOLISM; PLASMA; RISK FACTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; DIABETES MELLITUS, TYPE 2; FRANCE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84962685598     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv153     Document Type: Article

References (32)

1. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66:848-56.
2. Reid S, Barbui C. Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ 2010;340:c1468.
3. OECD. Panorama de la Santé 2013 Paris: Organisation for Economic Co-operation and Development. 2013. http://www.oecd-ilibrary.org/content/book/health_glance-2013-fr (10 July 2014, date last accessed).
4. Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief 2011; 76:1-8.
5. National Center for Health Statistics (US). Health, United States, 2013: With Special Feature on Prescription Drugs. Hyattsville, MD: National Center for Health Statistics (US), 2014
6. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002;63:817-25.
7. Lecadet J, Vidal P, Baris B, Vallier N, Fender P, Allemand H. Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine. I. Données nationales, 2000. (Psychotropic Medications: Prescriptions and Use in Metropolitan France. I. National Data, 2000). Rev Médicale Assur Mal 2003;34:75-84.
8. Gasquet I, Negre-Page S L, Fourrier A et al. Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study. L'Encéphale 2005;31:195-206.
9. Acquaviva E, Legleye S, Auleley GR, Deligne J, Carel D, Falissard BB. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry 2009;9:72.
10. Verdoux H, Begaud B. Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions? Br J Psychiatry 2004;185: 93-94.
11. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011;343:d4551.
12. Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther 2012;34:113-23.
13. Puras P, Mitchell PB. Chapter 2-Antidepressant drugs. In: Aronson JK (ed). Side Eff Drugs Annu 2014. http://www.sciencedirect.com/science/article/pii/B9780444626356000024 (10 July 2014, date last accessed).
14. Pan A, Sun Q, Okereke OI et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia 2012;55:63-72.
15. Barnard K, Peveler RC, Holt RIG. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 2013;36: 3337-45.
16. Vimalananda VG, Palmer JR, Gerlovin H et al. Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study. Diabetes Care 2014;37: 2211-17.
17. Yoon JM, Cho E-G, Lee H-K, Park SM. Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med 2013; 34:228-40.
18. Bhattacharjee S, Bhattacharya R, Kelley GA, Sambamoorthi U. Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 2013;29:273-84.
19. Kivimäki M, Batty GD, Jokela M et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry 2011;70:978-84.
20. Mezuk B, Johnson-Lawrence V, Lee H et al. Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes. Health Psychol 2013;32:254-63.
21. Erenmemisoglu A, Ozdogan UK, Saraymen R, Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J Pharm Pharmacol 1999;51:741-43.
22. Khoza S, Barner JC. Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports. Int J Clin Pharm 2011 Jun;33(3):484-492.
23. Ye Z, Chen L, Yang Z et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One 2011;6:e21551.
24. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med 2014;31: 773-86.
25. Pyykkönen A-J, Räikkönen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med 2012; 44:279-88.
26. Mojtabai R. Antidepressant use and glycemic control. Psychopharmacology (Berl) 2013;227:467-77.
27. Balkau B, Eschwege E, Tichet J, Marre M. Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.). Diabetes Metab 1997;23:428-34.
28. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.
29. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982c;38:963-74.
30. Gomez R, Huber J, Tombini G, Barros HMT. Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats. Braz J Med Biol Res 2001;34:57-64.
31. Sambamoorthi U, Ma Y, Findley PA, Rust G. Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries. J Diabetes 2013;5:327-35.
32. Nouwen A, Nefs G, Caramlau I et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes. Diabetes Care 2011;34:752-62.